Skip Nav

Contact Us

Chondrosarcoma CS Foundation, Inc.

Thank you for your interest in our company. Complete the form below to send us an email, or simply give us a call. We're looking forward to working with you.

  • 301-352-3042

    Uncategorized Posts

    Is the IDH Mutation a Good Target for Chondrosarcoma Treatment?

    April 30th, 2021

    Elena Cojocaru,
    Christopher Wilding,
    Bodil Engelman,
    Paul Huang &
    Robin L. Jones

    Current Molecular Biology Reports volume 6, pages1–9(2020)Cite this article

    Is the IDH Mutation a Good Target for Chondrosarcoma Treatment? |…

    Read Article

    Multigenerational and Transgenerational Effects of Dioxins As the Cause of Cancer


    Abstract

    Dioxins are ubiquitous and persistent environmental contaminants whose background levels are still reason for concern. There is mounting evidence from both epidemiological and experimental studies that paternal exposure to the most potent…

    Read Article

    In Memory of Sebastian


    Sebastien passed away July 14, 2020 from dedifferentiated chondrosarcoma. This narrative was written and submitted by his sister Stephanie Desjardins.

    In April 2019, my brother was diagnosed with a chondrosarcoma of chest wall on the right side…

    Read Article

    Memorial Sloan Kettering Information Session: Empowering Patients: Speak Up For Your Health

    April 29th, 2021

    Empowering Patients: Speak Up For Your Health
    Tuesday, May 11, 2021 at 12:00 PM ET

    Please consider registering to a special information session where our panel of experts will discuss the importance of advocating for patient care and treatment….

    Read Article

    Bone Cancer Research Trust Hosts Webinar on Anxiety and Fear of Recurrence

    April 24th, 2021

    The Bone Cancer Research Trust is hosting a free Support & Information Webinar. It features Carol Hughes who will provide a presentation on Managing the fear of recurrence, On Thursday 29th April

    We know that when treatment for primary bone…

    Read Article

    Proton therapy induces biologic response to attack treatment-resistant cancers

    April 23rd, 2021

    Proton therapy induces biologic response to attack treatment-resistant cancers February 17, 2021

    ROCHESTER, Minn. — Mayo Clinic researchers have developed a novel proton therapy technique to more specifically target cancer cells that resist…

    Read Article

    Cancer May Be Driven by DNA Outside of Chromosomes

    April 10th, 2021

    In the last decade, researchers have come to realize that tumors harbor bits of extrachromosomal DNA that can drive malignancy.

    Paul Mischel Apr 1, 2021
    338

    In the spring of 2012, my colleagues and I began to notice something strange in tumor…

    Read Article

    A Pilot Study of Lenvatinib Plus Pembrolizumab Immunotherapy in Patients with Advanced Sarcoma


    The purpose of this study is to learn whether combining lenvatinib and pembrolizumab is a safe and effective treatment for patients with metastatic soft tissue sarcomas that cannot be surgically removed. This study will include patients with…

    Read Article

    HARVARD SCIENTISTS EXCITED BY RESULTS ON NEW CANCER VACCINE

    April 5th, 2021

    A team of researchers say they’ve designed a personalized cancer vaccine capable of inducing an immune response that fights off melanoma, the deadliest form of skin cancer, that lasts for several years.
    In a study published in the journal Nature…

    Read Article

    Help Get The Word Out and the Virtual Dialogue Videos


    It’s Spring, Passover is ending, it’s Easter Sunday….. their is a light at the end of the dark tunnel of the pandemic and hope for a new beginning.

    With the knowledge of new medications and technologies for early diagnosis of Chondrosarcoma, my…

    Read Article